NASDAQ : DXR
Daxor Corporation — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 8.92 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 52.08M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 53.71M |
| Enterprise Value | 53.97M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 5.84M |
| Shares Outstanding | 5.84M |
| Shares Change (YoY) | +17.13% |
| Shares Change (QoQ) | +13.70% |
| Owned by Insiders (%) | 6.61% |
| Owned by Institutions (%) | 7.86% |
| Float | 2.90M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 8.62 |
| Forward PE | n/a |
| PS Ratio | 1,712.74 |
| Forward PS | n/a |
| PB Ratio | 1.04 |
| P/TBV Ratio | 1.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 8.67 |
| EV / Sales | 1,721.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.88 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -552.44 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 14.24% |
| Return on Assets (ROA) | -2.63% |
| Return on Invested Capital (ROIC) | -3.57% |
| Return on Capital Employed (ROCE) | -3.57% |
| Weighted Average Cost of Capital (WACC) | 6.19% |
| Revenue Per Employee | $697 |
| Profits Per Employee | $138,412 |
| Employee Count | 45 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.35 |
| 52-Week Price Change | -31.50% |
| 50-Day Moving Average | 10.43 |
| 200-Day Moving Average | 10.92 |
| Relative Strength Index (RSI) | 35.49 |
| Average Volume (20 Days) | 12,169 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3,374 |
| Short Previous Month | 6,959 |
| Short % of Shares Out | 0.06% |
| Short % of Float | 0.12% |
| Short Ratio (days to cover) | 0.13 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 31,360 |
| Gross Profit | 31,360 |
| Operating Income | -1.85M |
| Pretax Income | 6.23M |
| Net Income | 6.23M |
| EBITDA | n/a |
| EBIT | -1.85M |
| Earnings Per Share (EPS) | $1.07 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 51.83M |
| Book Value Per Share | 8.88 |
| Working Capital | 44,436 |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -8.18M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | -263,182 |
| Free Cash Flow | -8.18M |
| FCF Per Share | -$1.40 |
Margins
| Measure | Value |
|---|
| Gross Margin | 100.00% |
| Operating Margin | -5,894.33% |
| Pretax Margin | 19,861.41% |
| Profit Margin | 19,861.41% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -17.13% |
| Shareholder Yield | -17.13% |
| Earnings Yield | 11.60% |
| FCF Yield | -15.23% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $20.00 |
| Price Target Difference | 117.39% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |